Top

Osteoporosis International

Published in:

01-02-2015 | Original Article

Peak muscle mass in young men and sarcopenia in the ageing male

Authors: M. Frost, T. L. Nielsen, K. Brixen, M. Andersen

Published in: Osteoporosis International | Issue 2/2015

Abstract

Summary

The prevalence of sarcopenia increases with age. The diagnosis of sarcopenia relies in part on normative data on muscle mass, but these data are lacking. This study provides population-based reference data on muscle mass in young men, and these results may be used clinically for the diagnosis of sarcopenia in men.

Introduction

The ageing population increases the prevalence of sarcopenia. Estimation of normative data on muscle mass in young men during the peak of anabolic hormones is necessary for the diagnosis of sarcopenia in ageing males. The purposes of this study were to provide population-based reference data on lean body mass (LBM) in young men during the time of peak levels of GH/IGF-1 and testosterone and further to apply the reference data on a population-based sample of men aged 60–74 years to estimate the prevalence of sarcopenia.

Methods

This is a cross-sectional, population-based single-centre study. Our participants are from random selection of 783 men, aged 20–29 years, and 600 men, aged 60–74 years. LBM was assessed by dual-energy X-ray absorptiometry (DXA). LBM T-scores were calculated on the basis of LBM in the young participants. Muscle function in the lower extremities was measured using a leg extension power (LEP) rig in the ageing participants.

Results

Total lean body mass (TLB) was (mean (SD)) 64.7 kg (6.8) in the young and 60.4 kg (6.4) in the ageing men (p < 0.001). Lower extremity lean mass (LELB) was 22.0 kg (2.6) in the young and 19.2 kg (2.4) in the ageing men (p < 0.001). In the ageing men, TLB and LELB T-scores were −0.64 (0.94) and −1.09 (0.94). A total of 4.8 and 8.5 % had a TLB or LELB T-score of less than −2 and a LEP in the lowest quartile.

Conclusions

This study provides population-based reference data on LBM in men, and these data may be used clinically for the diagnosis of sarcopenia.

Delmonico MJ, Harris TB, Lee JS et al (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55(5):769–774PubMedCrossRef

Roubenoff R (2001) Origins and clinical relevance of sarcopenia. Can J Appl Physiol 26(1):78–89PubMedCrossRef

Gallagher D, Visser M, De Meersman RE et al (1997) Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 83(1):229–239PubMed

Wickham C, Cooper C, Margetts BM, Barker DJ (1989) Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing 18(1):47–51PubMedCrossRef

Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763PubMedCrossRef

Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–896PubMedCrossRef

Melton LJ 3rd, Khosla S, Crowson CS, O’Connor MK, O’Fallon WM, Riggs BL (2000) Epidemiology of sarcopenia. J Am Geriatr Soc 48(6):625–630PubMed

Ferrucci L, Guralnik JM, Buchner D et al (1997) Departures from linearity in the relationship between measures of muscular strength and physical performance of the lower extremities: the women’s health and aging study. J Gerontol A Biol Sci Med Sci 52(5):M275–M285PubMedCrossRef

Goodpaster BH, Park SW, Harris TB et al (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61(10):1059–1064PubMedCrossRef

10.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423PubMedCentralPubMedCrossRef

11.

Patel HP, Syddall HE, Jameson K et al (2013) Prevalence of sarcopenia in community-dwelling older people in the UK using the European working group on sarcopenia in older people (EWGSOP) definition: findings from the Hertfordshire cohort study (HCS). Age Ageing 42(3):378–384PubMedCentralPubMedCrossRef

12.

Cherin P, Voronska E, Fraoucene N, de Jaeger C (2014) Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years. Aging Clin Exp Res 26(2):137–146. doi:10.1007/s40520-013-0132-8.

13.

Bijlsma AY, Meskers CG, van den Eshof N et al (2014) Diagnostic criteria for sarcopenia and physical performance. Age (Dordr) 36(1):275–285CrossRef

14.

Morley JE (2008) Sarcopenia: diagnosis and treatment. J Nutr Health Aging 12(7):452–456PubMedCrossRef

15.

Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Ferrucci L (2003) A comparison of leg power and leg strength within the InCHIANTI study: which influences mobility more? J Gerontol A Biol Sci Med Sci 58(8):728–733PubMedCrossRef

16.

Skelton DA, Kennedy J, Rutherford OM (2002) Explosive power and asymmetry in leg muscle function in frequent fallers and non-fallers aged over 65. Age Ageing 31(2):119–125PubMedCrossRef

17.

Kuo HK, Leveille SG, Yen CJ et al (2006) Exploring how peak leg power and usual gait speed are linked to late-life disability: data from the national health and nutrition examination survey (NHANES), 1999–2002. Am J Phys Med Rehabil 85(8):650–658PubMedCentralPubMedCrossRef

18.

McDermott MM, Liu K, Tian L et al (2012) Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. J Am Coll Cardiol 59(13):1159–1167PubMedCentralPubMedCrossRef

19.

Nielsen TL, Wraae K, Brixen K, Hermann AP, Andersen M, Hagen C (2006) Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense androgen study. Int J Obes (Lond) 30(5):805–815CrossRef

20.

Frost M, Wraae K, Gudex C et al (2012) Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing 41(2):177–183. doi:10.1093/ageing/afr153.

21.

Frost M, Wraae K, Nielsen T et al (2013) Similar reference intervals for total testosterone in healthy young and elderly men: results from the Odense Androgen Study. Clin Endocrinol (Oxf) 78(5):743–751. doi:10.1111/cen.12042.

22.

Bassey EJ, Short AH (1990) A new method for measuring power output in a single leg extension: feasibility, reliability and validity. Eur J Appl Physiol Occup Physiol 60(5):385–390PubMedCrossRef

23.

Blackwell T, Cawthon PM, Marshall LM, Brand R (2009) Consistency of leg extension power assessments in older men: the osteoporotic fractures in Men (MrOS) study. Am J Phys Med Rehabil 88(11):934–940PubMedCentralPubMedCrossRef

24.

Volpato S, Bianchi L, Cherubini A et al (2014) Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 69(4):438–446. doi:10.1093/gerona/glt149.

25.

Frost M, Wraae K, Abrahamsen B et al (2012) Osteoporosis and vertebral fractures in men aged 60–74 years. Age Ageing 41(2):171–177PubMedCrossRef

26.

Aadahl M, Beyer N, Linneberg A, Thuesen BH, Jorgensen T (2011) Grip strength and lower limb extension power in 19–72-year-old Danish men and women: the Health2006 study. BMJ Open 1(2):e000192PubMedCentralPubMedCrossRef

27.

Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69(5):547–558PubMedCentralPubMedCrossRef

Title: Peak muscle mass in young men and sarcopenia in the ageing male
Authors: M. Frost
T. L. Nielsen
K. Brixen
M. Andersen
Publication date: 01-02-2015
Publisher: Springer London
Published in: Osteoporosis International / Issue 2/2015
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-014-2960-6

At a glance: The STEP trials

Springer Medicine

Peak muscle mass in young men and sarcopenia in the ageing male

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2015

Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective

Electrical stimulation at the dorsal root ganglion preserves trabecular bone mass and microarchitecture of the tibia in hindlimb-unloaded rats

Bone turnover markers predict hip bone loss in elderly European men: results of the European Male Ageing Study (EMAS)

Underdevelopment of trabecular bone microarchitecture in the distal femur of nonambulatory children with cerebral palsy becomes more pronounced with distance from the growth plate

Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)

Influence of chronic stroke impairments on bone strength index of the tibial distal epiphysis and diaphysis